Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)
February 22, 2021 07:26 AM ESTUpdated 10:41 AM
Coronavirus

Covid-19 roundup: Serum In­sti­tute chief asks coun­tries to 'please be pa­tien­t'; Sanofi and Glax­o­SmithK­line en­ter PhII with 're­fined' vac­cine for­mu­la­tion

Nicole DeFeudis

Editor

Serum In­sti­tute of In­dia CEO Adar Poon­awal­la has asked coun­tries wait­ing for dos­es of As­traZeneca and Ox­ford Uni­ver­si­ty’s vac­cine to “please be pa­tient,” as the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times